Clincosm LogoSign in Get a demo

hiv infection

Showing 1 - 25 of 554
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou

Recruiting
  • HIV Infection
  • Combined Antiretroviral Therapy
    • Hangzhou, Zhejiang, China
      Zhikai Wan
    Aug 30, 2023

    HIV Infection Trial (dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen)

    Not yet recruiting
    • HIV Infection
    • dolutegravir (DTG)/emtricitabine (FTC)/tenofovir alafenamide (TAF) regimen
    • (no location specified)
    Aug 8, 2023

    Depression, HIV Infection Trial in Saint Louis, Masaka (Suubi-Mhealth)

    Recruiting
    • Depression
    • HIV Infection
    • Suubi-Mhealth
    • Saint Louis, Missouri
    • +1 more
    Jul 19, 2023

    HIV Infection Trial (DOR/ISL)

    Not yet recruiting
    • HIV Infection
    • (no location specified)
    Mar 1, 2023

    AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,

    Recruiting
    • AIDS-Related Anal Carcinoma
    • +22 more
    • San Francisco, California
    • +8 more
    Jan 27, 2023

    AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,

    Recruiting
    • AIDS-Related Anal Carcinoma
    • +4 more
    • Biopsy
    • +5 more
    • San Francisco, California
    • +2 more
    Jan 24, 2023

    HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Los Angeles, California
    • +11 more
    Jan 13, 2023

    Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,

    Completed
    Has Results
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Cabozantinib S-malate
    • +2 more
    • La Jolla, California
    • +19 more
    Dec 14, 2022

    Collecting Blood and Tissue Sample Donations for Research for

    Not yet recruiting
    • Anal Carcinoma
    • +11 more
    • Biospecimen Collection
    • (no location specified)
    Dec 21, 2022

    HIV Infection, Adherence, Medication, Adherence, Treatment Trial in Boston (Next-generation Reader and ID-Cap System, Truvada

    Recruiting
    • HIV Infection
    • +4 more
    • Next-generation Reader and ID-Cap System
    • +2 more
    • Boston, Massachusetts
      Fenway Health
    Dec 20, 2022

    Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

    Recruiting
    • Hepatitis C Infection
    • HIV Infection
    • Glecaprevir/Pibrentasvir (G/P)
    • Ribavirin (RBV)
    • San Diego, California
    • +15 more
    Dec 19, 2022

    Sexual Risks in Prep Users

    Completed
    • HIV Infection
    • +3 more
    • PrEP
    • Strasbourg, France
      Les Hôpitaux Universitaires de Strasbourg
    Dec 16, 2022

    HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

    Recruiting
    • HIV Infection
    • +10 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • La Jolla, California
    • +3 more
    Dec 7, 2022

    HIV Infection Trial in New York (Colonoscopy)

    Not yet recruiting
    • HIV Infection
    • Colonoscopy
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 7, 2022

    HIV Infection, Hepatitis B Trial in Worldwide (HEPLISAV-B, ENGERIX-B)

    Recruiting
    • HIV Infection
    • Hepatitis B
    • HEPLISAV-B
    • ENGERIX-B
    • Birmingham, Alabama
    • +47 more
    Dec 13, 2022

    Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

    Active, not recruiting
    • SARS-CoV-2 RNA Vaccines
    • HIV Infection
    • SARS-CoV-2 Vaccine
    • Sevilla, Spain
      Virgen del Rocio University Hospital
    Dec 1, 2022

    Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +8 more
    • Ipilimumab
    • Nivolumab
    • La Jolla, California
    • +34 more
    Nov 29, 2022

    The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

    Not yet recruiting
    • HIV Infection
    • Anti-HIV Agents
    • (no location specified)
    Nov 4, 2022

    Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

    Recruiting
    • Acute Erythroid Leukemia
    • +10 more
    • San Francisco, California
    • +5 more
    Nov 1, 2022

    HIV Infection, Vaginal Atrophy, Menopause Trial in Bronx (Estradiol Vaginal Insert)

    Recruiting
    • HIV Infection
    • +8 more
    • Estradiol Vaginal Insert
    • Bronx, New York
      Albert Einstein College of Medicine
    Nov 3, 2022

    HIV Infection, Sexually Transmitted Infections, Implementation Trial in Eugene (Training Tool for Preventing HIV/AIDS among

    Not yet recruiting
    • HIV Infection
    • +2 more
    • Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life
    • Eugene, Oregon
      Oregon Research Behavioral Intervention Strategies, Inc.
    Oct 28, 2022

    HIV Infection Trial in Thulamahashi (HIV rapid test)

    Recruiting
    • HIV Infection
    • HIV rapid test
    • Thulamahashi, Mpumalanga, South Africa
      Thulamahashe Health Facility
    Oct 25, 2022

    Cancer in People Living With HIV/AIDS at Cancer Centers in Latin

    Active, not recruiting
    • HIV Infection
    • +3 more
    • Medical Chart Review
    • Survey Administration
    • Buenos Aires, Argentina
    • +3 more
    Oct 20, 2022

    HIV-infected Non-malarial Febrile Illnesses Using Metagenomic

    Recruiting
    • HIV Infection
      • Mulago, Uganda
        Baylor College of Medicine Children's Foundation-Uganda
      Oct 4, 2022

      HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

      Terminated
      Has Results
      • HIV Infection
      • Recombinant Interleukin-2
      • Cleveland, Ohio
        AIDS Clinical Trials Unit
      Sep 1, 2022